« Return to News | Study Conduct

Synexus Expands Operations in Poland

Wednesday, July 7, 2010 08:45 AM

Synexus, an international recruiter and operator of clinical trials, is expanding its operations in Gdynia, Poland. It has also recently increased the capacity of its original center in Wroclaw. The new dedicated research center in Gdynia will have the capacity for four full-time investigators and will include a wide range of diagnostic instruments to cover Synexus’ expanding therapy area coverage. Dr. Radoslaw Janiak, Synexus Country Manager for Poland, said, “Being part of Synexus’ worldwide operations means that we are increasingly involved in large global clinical trials. We are able to recruit the right numbers of patients within the right time frame, and that’s exactly what sponsors are looking for. We are seeing considerable interest from a number of leading Pharmas and CROs who are keen on the developments we have under way to increase our capacity here.” Manchester, England-based Synexus has been operating in Poland since 2006 and expanded its operations there in 2009 when it acquired three new dedicated research centers in Warsaw, Gdynia and Katowice, following its takeover of CLCC.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.